These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1763646)

  • 1. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease.
    Fraysse B; Bebear JP; Dubreuil C; Berges C; Dauman R
    Acta Otolaryngol Suppl; 1991; 490():1-10. PubMed ID: 1763646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunarizine and betahistine. Two different therapeutic approaches in vertigo compared in a double-blind study.
    Elbaz P
    Acta Otolaryngol Suppl; 1988; 460():143-8. PubMed ID: 3074614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trimetazidine versus betahistine in Ménière's disease. A double blind method].
    Martini A; De Domenico F
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():20-7. PubMed ID: 2240995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Kluyskens P; Lambert P; D'Hooge D
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.
    Mira E; Guidetti G; Ghilardi L; Fattori B; Malannino N; Maiolino L; Mora R; Ottoboni S; Pagnini P; Leprini M; Pallestrini E; Passali D; Nuti D; Russolo M; Tirelli G; Simoncelli C; Brizi S; Vicini C; Frasconi P
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):73-7. PubMed ID: 12582782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term therapy of Ménière's disease. Comparison of the effects of betahistine dihydrochloride and hydrochlorothiazide].
    Petermann W; Mulch G
    Fortschr Med; 1982 Mar; 100(10):431-5. PubMed ID: 7040186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of medical treatment for Menière's disease, using a double-blind controlled study.
    Mizukoshi K; Watanabe I; Matsunaga T; Hinoki M; Komatsuzaki A; Takayasu S; Tokita T; Matsuoka I; Matsunaga T; Tanaka T
    Am J Otol; 1988 Sep; 9(5):418-22. PubMed ID: 3202132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Meniere disease with betahistine dimesilate (Aequamen)--double-blind study versus placebo (crossover)].
    Meyer ED
    Laryngol Rhinol Otol (Stuttg); 1985 May; 64(5):269-72. PubMed ID: 3894841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Menière's disease with betahistine (author's transl)].
    Stupp H; Kahl S
    HNO; 1976 Sep; 24(9):320-5. PubMed ID: 965272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial.
    Strupp M; Hupert D; Frenzel C; Wagner J; Hahn A; Jahn K; Zingler VC; Mansmann U; Brandt T
    Acta Otolaryngol; 2008 May; 128(5):520-4. PubMed ID: 18421605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Picrotoxin in the treatment of Menière's disease].
    Weikert S; Rotter A; Scherer H; Hölzl M
    Laryngorhinootologie; 2008 Dec; 87(12):862-6. PubMed ID: 18720328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled clinical trial comparing the effect of betahistine hydrochloride and prochlorperazine maleate on patients with Meniére's disease.
    Aantaa E; Skinhoj A
    Ann Clin Res; 1976 Aug; 8(4):284-7. PubMed ID: 793500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials of betahistine hydrochloride in the treatment of Ménière's disease.
    Segers JM; Boedts D
    Acta Otorhinolaryngol Belg; 1975; 29(5):814-21. PubMed ID: 1224965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
    Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
    BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss.
    Redon C; Lopez C; Bernard-Demanze L; Dumitrescu M; Magnan J; Lacour M; Borel L
    J Clin Pharmacol; 2011 Apr; 51(4):538-48. PubMed ID: 20940335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.
    Nauta JJ
    Eur Arch Otorhinolaryngol; 2014 May; 271(5):887-97. PubMed ID: 23778722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo.
    Albera R; Ciuffolotti R; Di Cicco M; De Benedittis G; Grazioli I; Melzi G; Mira E; Pallestrini E; Passali D; Serra A; Vicini C
    Acta Otolaryngol; 2003 Jun; 123(5):588-93. PubMed ID: 12875580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Betahistine treatment of Menière's disease (author's transl)].
    Chüden HG
    Laryngol Rhinol Otol (Stuttg); 1978 Nov; 57(11):997-1007. PubMed ID: 723406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.